Sponsor:
Massachusetts General Hospital
Code:
NCT07014293
Conditions
Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Enhanced Usual Care
SMART3RP-Lymphoma
Brief summary:
Conditions
Lymphoma
Study ID
NCT07014293
Start date
Aug 31, 2026
Status verified date
Aug, 2026
Completion date
Jul 1, 2030
Anticipated
Primary completion date
Jul 1, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
254 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
other: Enhanced Usual Care
experimental: SMART3RP-Lymphoma
Interventions
Enhanced Usual Care
SMART3RP-Lymphoma
Primary outcome measure
Locations
Mass General Brigham
Recruiting
Boston, Massachusetts, United States, 02114
Contacts
Principal Investigator:
Giselle Perez, PhD
Sponsor
Massachusetts General Hospital
Last update posted
Aug 11, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2026-08-11.